Back to Search
Start Over
Pharmacological rationale for antihypertensive drug choice on COVID‐19–affected patients: ACEI/ARB might not increase their susceptibility
- Source :
- Journal of Cellular and Molecular Medicine
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
- Subjects :
- 2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
medicine.drug_class
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Angiotensin-Converting Enzyme Inhibitors
Comorbidity
Pharmacology
Letter to the Editors
Angiotensin Receptor Antagonists
Animals
Humans
Medicine
Acei arb
Antihypertensive drug
Letter to the Editor
Antihypertensive Agents
business.industry
COVID-19
Cell Biology
medicine.disease
COVID-19 Drug Treatment
Premenopause
Hypertension
Angiotensin-converting enzyme 2
Molecular Medicine
Female
Angiotensin-Converting Enzyme 2
business
Subjects
Details
- ISSN :
- 15824934 and 15821838
- Volume :
- 24
- Database :
- OpenAIRE
- Journal :
- Journal of Cellular and Molecular Medicine
- Accession number :
- edsair.doi.dedup.....0d46f801b8b9857127a53613143bfda1